(Total Views: 575)
Posted On: 01/29/2022 1:31:57 PM
Post# of 154739
Sorry
Dr. Kelly will speak tomorrow, November 30, 2021, at 2:55pm PST about emerging
approaches to antivirals, specifically focusing on leronlimab. Dr. Kelly’s
segment is entitled, “Leronlimab – a platform mab CCR5 antagonist and its role
in antiviral indications.”
Dr. Kelly will speak tomorrow, November 30, 2021, at 2:55pm PST about emerging
approaches to antivirals, specifically focusing on leronlimab. Dr. Kelly’s
segment is entitled, “Leronlimab – a platform mab CCR5 antagonist and its role
in antiviral indications.”
(0)
(0)
